Latest Financial Results
FY 2023
Fiscal Year Ended Dec 31, 2023
Latest Annual Filing
For Fiscal Year Ending Dec 31, 2023
Report Links
Email Alerts
Sign up today and receive company updates straight to your inbox.
Company Overview
ProMIS™ Neurosciences, Inc. (Nasdaq: PMN), is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). The Company has offices in Toronto, Ontario, and Cambridge, Massachusetts.
Toronto, Canada Office
Address
1920 Yonge Street
Suite 200
Toronto, ON M4S 3E2
Canada
Cambridge, MA U.S. Office
Address
Cambridge Innovation Center
1 Broadway
Cambridge, MA 02142
U.S.A.